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Abstract
Auris atresia (AA) is a congenital pathology characterized by aplasia or hypopla-
sia of the external ear with associated middle ear malformation. The AA has a dif-
ferent degree of severity, and the severe form of the disorder presents no identifiable 
ear canal (complete atresia) and absence or significative underdevelopment of the 
middle ear structures. Sometimes AA is associated with a malformation of the ear 
called “microtia.” The alterations of the external auditory canal and of the middle ear 
structures are responsible for the conductive hearing loss which affects the patients. 
The hearing restoration procedures may recreate a normal external and middle ear 
anatomy to favor the recovery of the hearing function, or the surgeon may simply 
restore the hearing capacity through bypassing the malformed structures by bone-
anchored hearing implants (BAHIs). The restoring of normal anatomy is generally 
associated with episode of restenosis of the external ear canal due to bony regrowth. 
The formulation of a therapeutic strategy may be supported by using Jahrsdoerfer 
classification to identify the severity of malformation. In the chapter we discuss vari-
ous bone anchoring prostheses currently used (Baha, Ponto, Alpha2 by Sophono, 
Bonebridge) and the results that can be obtained by the use of these implants.
Keywords: congenital aural atresia, hearing loss, hearing restoration, bone-anchored 
hearing implant, memory function
1. Introduction
Congenital aural atresia (CAA) is a congenital malformation of the ear that 
causes both esthetic and functional impairments. The malformation presents differ-
ent severities of impairment; CAA may be the only malformation in the body or be 
associated with other malformation as observed in syndromic patients.
CAA is a failure in the ear development that happens in the first gestation’ 
weeks; the failure may be complete by affecting the external and the middle ear or 
partial, as, for example, a stenotic external canal with normal middle ear structures.
In all cases, the hearing function is impaired, despite having different hearing 
threshold.
Our group showed that independently from the severity of the hearing impair-
ment, children with hearing loss present a reduction of the memory function and 
scholar abilities [1], so the restoration of hearing function should be considered 
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the first goal in CAA followed, eventually, before the adolescent age by an esthetic 
reconstruction of the external ear [2]. In 1992 Jahrsdoerfer et al. [3] proposed a CT 
grading system for CAA that was shown to correlate with postoperative hearing 
outcomes, as a supporting method during the decisional process of treatment of 
CCA malformation; the suggestion of the author was to treat the high score of mal-
formation with external canal bone reconstruction and eventually ossiculoplasty, 
while in the case of lower scores, the bone-anchored hearing implants (BAHIs) 
were the most appropriate treatment.
Other more recent scoring systems as the Lübeck score have been proposed; 
this system is based on strong analyses conducted on high-resolution CT scan. The 
proposed method used a 16-score grading for addressing to the best ear implant [4] 
that has the same efficacy as the Jahrsdoerfer et al. classification [3].
In this chapter we discuss the CCA management with BAHIs by illustrating the 
different implants available on the market and the implantation method and finally 
reporting the results that we obtained in more than 10 years of experience with 
these systems.
2. Congenital auris atresia (CCA)
Congenital aural atresia is an ear malformation that may have different severity 
and may affect the external ear only or the middle ear too. The ear malformation 
may be a single problem or be part of a syndromic picture. An altered development 
of the first and second branchial arches and the first branchial cleft may be respon-
sible for the CCA [5].
Schuknecht [6] classified four degree of severity based on the combination of 
high-resolution computer tomography (CT) scan and surgical findings: (1) Type 
Figure 1. 
The image shows the four types of CAA as described by Schuknecht. In Type A, the yellow indicates the presence 
of the cholesteatoma behind the meatal stenosis. The gray areas in Types B, C, and D represent the portion with 
bone atresia. The red dot in type D shows the aberrant exit of facial nerve.
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A: narrowing of the fibrocartilaginous canal and presence of cholesteatoma distal 
to the stenotic area. (2) Type B: narrowing and tortuosity of fibrocartilaginous and 
bony part of the canal, commonly associated with abnormal tympanic membrane 
and malleus. (3) Type C: complete atresia with different combination of fibrous tis-
sue and bone. Typically, malleus and incus are fused together, the manubrium and 
the tympanic membrane are missing, and the stapes is mobile. (4) Type D: totally 
atresia with decreased pneumatization of mastoid. More severe ossicular anomalies 
than type C and frequently the facial nerve being aberrant (Figure 1).
Other authors classified the CAA; one of the most famous is Weerda [7] 
that classified these malformations in three types (A, B, and C), while Altmann 
described a histopathological classification correlating the severity of CAA [8] by 
identifying three categories: mildly, moderately, and severely malformed types. 
Many authors have since modified this classification system, further subclassifying 
type II based on the surgical findings and functional outcome [9].
3. Embryology and etiopathogenesis of CAA
The mandibular (I) and the hyoid (II) branchial arches contribute to the 
auricular development, and both may be involved in the etiopathogenesis of 
CAA. Auricular pinna starts to develop between the third to sixth weeks of embry-
onic life, when hillocks appear on the arches, and its formation is complete at the 
fourth month of gestation. The basis of tragus, the helical root, and the superior 
part of the helix comes from the anterior three hillocks, derived from the first arch. 
The posterior hillock that derives from second arch is responsible for the formation 
of the antihelix, antitragus, and lobule. The middle ear cavity derives from the first 
pharyngeal arch starting from 4 weeks of gestation. The pinna develops around the 
external meatus which becomes canalized at week 28 of embryologic life. At 8 weeks 
the middle ear cleft is formed, and the cavity is complete developed at 30 weeks. 
The first arch cartilage generates malleus and incus by 8 weeks of gestation that 
start to ossify at the 4 months of pregnancy. From the second arch, cartilage comes 
out the stapes except the medial lamina of the footplate which derives from the otic 
capsule [10]. At week 9, ectodermal cells proliferate, fill the meatus lumen, and 
form the “meatal plug” (MP); then on week 10, the MP extends in a disclike fashion 
by following a horizontal plane, and the internal part of MP starts to thin for gen-
erating the future tympanic membrane. At the same time, the plug in the proximal 
portion of the neck starts to be resorbed. At week 13 the MP is in contact with the 
primordial malleus, and this contact will contribute to the thinness of internal part 
of MP that will create the tympanic membrane at week 15. At week 16 the external 
ear canal is fully patent but still narrow and curved. At week 18 the meatus is fully 
extended and starts its opening that will be completed at 28 weeks [11].
Any type of adverse event that occurs during the 4 and 25 weeks of gestation 
and interrupts one of more of these developments may be responsible for one of 
the different types of CAA. The adverse event may be related to genetic aberra-
tions, vascular accident (fetal hypoxia), teratogenic substances (aminoglycoside 
antibiotics, hydantoin, alcohol, nicotine, herbicides), maternal infection (rubella, 
Cytomegalovirus, measles, hepatitis, toxoplasmosis, lues), and maternal metabolic 
disease (deficiency of thyroid hormone or diabetes) [12].
CAA may be a single malformation or be associated with other malformations 
as in the case of oto-facial dysostosis (Treacher-Collins syndrome, Goldenhar 
syndrome), craniofacial dysostosis (Crouzon syndrome, Apert syndrome), oto-
cervical dysostosis (Klippel-Feil syndrome, Wildervanck syndrome), oto-skeletal 
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dysostosis (Van der Hoeve-De Klein syndrome, Albers-Schonberg disease), and 
chromosomal syndromes (trisomy 13, 18, 21, and 18q syndrome) [2].
4. Indications to use BAHI in patients with CAA
CAA is predominantly unilateral (ca. 70–90%) and the malformation mostly 
affects the right ear, perhaps because this side can suffer more frequently of 
hypoperfusion even rather that the left side in which the heart is located and that 
generally has a pressure 10 mmHg higher to the right side. The incidence of ear 
malformations is approximately 1 in 3800 newborns. Some children may present 
a bilateral CAA, when the malformation is not an isolated disease, but it is contex-
tualized in a syndrome as, for example, CHARGE syndrome, in which children are 
affected by bilateral atresia up to 60% of cases [13].
Patients may be affected from different severity of external and middle ear 
malformation (Figure 1): due to the severity we can identify different forms of 
hearing loss. CAA typically results in conductive hearing loss (CHL) in 80–90% of 
the cases with the remaining patients demonstrating a sensorineural hearing loss 
(SNHL) component [10]. The CHL is typically in the moderate hearing loss range of 
40–60 dB; this is the range in which BAHIs work better (Figure 2).
In the case of children suffering from unilateral CAA [14] and sensorineural 
hearing loss (10–20% of children with CAA), BAHI may be used for restoring 
the hearing function if the contralateral normal hearing function is preserved 
[15–17].
We use to utilize the Jahrsdoerfer et al. method during our decisional process 
for identifying the most appropriate surgery technique that has to be used. The 
authors proposed a CT grading system for CAA that was shown to correlate with 
postoperative hearing outcomes; based on the scores reached in the preliminary 
Figure 2. 
The back image shows the ideal condition to use BAHI, while the supra-impressed yellow banana illustrates 
the distribution of vocal frequency. CHL that presents an auditory threshold within 45 dB may benefit from 
a BAHI because the implant guarantees a good recover of auditory functions in the range between 500 and 
4000 Hz.
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patient evaluation, the authors proposed different surgical options. In the case of 
high scores (better option), a canaloplasty with eventual ossiculoplasty may be a 
good option for the treatment of CAA, while, in the case of low scores, the authors’ 
suggestion is to use a BAHI [3]. Specifically, the authors concluded that the patient 
with a score of 8–9 is a very good candidate (80% chance to reach postoperative 
PTA threshold of 30 dB or lower) for surgical reconstruction of the auditory canal 
and the middle ear, while a score of 5/6 or less disqualifies patients for surgery. 
Furthermore, they identified that syndromic patients rarely present a grade higher 
than 6/7 and, in general, are poor surgical candidates (Table 1).
Anyway even in the case of success (Table 2), a surgical reconstruction presents 
a several postsurgical complication as stenosis of the new external auditory canal 
(15–20%), recurrent otitis externa (10%), sensorineural hearing loss (5%) choleste-
atoma (2–4%), and facial nerve injury (0.1%), and often a hearing aid is necessary 
to allow a good hearing function [15, 18–21].
Parameter Points
Stapes present 2
Oval window open 1
Middle ear space 1
Facial nerve normal 1
Malleus/incus complex presence 1
Mastoid well pneumatized 1
Incus-stapes connection 1
Round window normal 1
Appearance external ear 1
Total available points 10
Table 1. 
The Jahrsdoerfer grading system of candidacy for CAA repair.
Authors and year Number of patients Mean PTA ≤ 30 dB HL
Lambert, 1988 16 12 (67%)
Bellucci, 1981 71 39 (55%)
Mattox and Fisch, 1986 11 5 (45%)
De la Cruz et al., 1985 56 41 (73%)
Schuknecht, 1989 50 15 (50%)
Jahrsdoerfer, 1992 126 61 (48%)
Murphy et al., 1997 19 4 (21%) (20 dB)
Teufert and De la Cruz, 2004 115 55 (48%)
Digoy and Cueva, 2007 54 27 (50%)
El-Hoshy, 2008 40 26 (65%)
Yellon et al., 2011 19 8 (45%)
Nadaraja et al., 2013 390 235 (60.3%)
Table 2. 
The experiences of different authors on the surgical reconstruction of external ear canal are reported.
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Based on our experience and according to the Jahrsdoerfer study, we can affirm 
that patients with CAA and a score of < 7 rarely benefit from an external and middle 
ear reconstruction with good functional results. In such cases, the implantation of 
a BAHI is a viable option for obtaining a stable, satisfactory, and long-term result in 
terms of hearing function recovery [18]. In conclusion we think that BAHI could be 
quite always the best method for restoring hearing function in patients with CAA, 
even in the case of high score in the Jahrsdoerfer grading system.
5. Available product
The hearing restoration by bone stimulation did not obtain an immediate 
success; in fact in 1920 the first electronic implantable device was the preferred 
method, and bone stimulation prostheses were considered as the last alterna-
tive. Furthermore, after the Second World War, with the advent of transistor, the 
electronic prosthesis became smaller and more manageable, similar to the actual 
hearing aids. Anyway, in the recent decades, thanks to the new discoveries which 
better explained the physiologic stimulation of the inner by bone stimulation and 
to the improved technologies that miniaturize the systems and make the system 
implantable (BAHI Figure 3), the system is widely used for the treatment of hear-
ing impairments [21, 22]. BAHI solved the old problems related to the external bone 
stimulation as the difficulties in maintaining constant position and correct pres-
sure on the mastoid and, in addition, the reduced bone stimulation due to the skin 
impedance [23, 24].
In the light of multiple observations and experiments, it was concluded that the 
bone pathway is a type of natural sound conduction and that the sound characteris-
tics are normal and quite similar to that conducted by air.
The BAHI solves the problems of the traditional retro-auricular bone stimula-
tion as poor performance due to inadequate contact between the vibrator and the 
skin, pain or decubitus at the site of contact, and poor esthetic acceptance of arch 
prostheses by combining a pin implanted in the temporal bone with an external 
transducer; the vibration of the transducer on the bone induces a stimulation of the 
inner ear cells with consequently sound perception.
Figure 3. 
On the left side, the transcutaneous BAHI, and on the right side, the percutaneous.
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Figure 4. 
Percutaneous BAHI (PONTO) produced by Oticon Medical.
Figure 5 
On the top of the image, a semi-implantable transcutaneous device BONEBRIDGE (Medel) and on the bottom 
another model of transcutaneous BAHI ALPHA 2 by SOPHONO (Medtronic).
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The coupling between the pin and the transducer determines the type of BAHI: 
percutaneous or transcutaneous. Both methods of implant need a surgery.
The difference between the transcutaneous and the percutaneous system is the 
way in which the titanium screw is placed related to the skin plan; in the first one, 
the skin is surgically open, and the abutment is placed directly on the mastoid; then 
the surgical opening is closed by suturing the skin [25]. The percutaneous system 
instead consists of a titanium implant placed “through” the skin by perforating it [26].
All BAHI systems are composed of three main components:
1. An internal titanium fixture that is surgically anchored to the temporal bone 
behind the ear
2. An external abutment that is connected to the implant at the time of surgery
3. An external sound processor that is snapped on to the abutment
All systems currently available on the market present these characteristics: high 
amplification power, working independently in the presence/absence of the ear canal 
and middle ear, a direct bone transmission giving a clear sound, may be tested preop-
eratively, and all systems being quite similar in terms of comfort [27–29] (Figures 3–5).
6. Temporal bone anatomy and BAHI
Surgeons have to keep in mind the normal anatomy of temporal bone because 
it is helpful for remembering the anatomic landmarks when severe malformations 
occurred in the patient that should be implanted.
When CAA is associated with microtia, the main anatomic landmarks are the 
zygomatic process (image 7 sagittal plane view); in fact this structure is generally 
quite preserved also in the case of craniofacial malformation.
In the case of the absence of zygomatic process, the squamosal suture should be 
identified as alternative landmarks (Figure 6).
Figure 6. 
The normal anatomy of human temporal bone in sagittal and coronal views. The red circle indicates the 
zygomatic process, the only landmark that may be present in the case of CAA associated with craniofacial 
malformation (Figures 7–9).
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Figure 7. 
The image shows the squamosal suture in a normal head. In the left side the cranium of a child before the 
closure of the suture; in the right the squamosal suture as appears in the adult head.
Figure 8. 
CT scan high-resolution images. (A) Type D CAA with preservation of the normal mastoid pneumatization. 
The red arrow indicates the squamosal suture. (B) Type D CAA with absence of mastoid pneumatization; the 
red arrow shows the clear presence of the squamosal suture that is still not closed.
Figure 9. 
(A) CAA in a non-syndromic patient with complete preservation of zygomatic arch anatomy (red rectangle). 
(B) CAA in a syndromic patient; the zygomatic arch is extremely malformed (red rectangle) and cannot be 
used as a surgical anatomic landmark. The squamosal suture is well identifiable (yellow arrow) and can be 
used as an alternative to zygomatic arch.
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7. Surgical method of implant and timing
The FDA recommends to apply the device in children not younger than 5 years. 
Authors say that the ideal age for implanting a BAHI is between 2 and 4 years, 
because at this age the thickness of retromastoid bone (2.5–3 mm) allows to perform 
a totally safe surgery, without risk of damaging the dura. Additionally, regarding 
the age of implant, we have to consider that children need to possess a sufficient 
manual dexterity to maintain the device and a good psychological tendency to 
follow the suggestions of parents and caregivers. We usually correct hearing aids 
before 5 years by using an elastic band (Softband).
The Tjellström et al. technique, proposed in 1977, suggest the creation of a 
thin muscle-cutaneous flap. The main disadvantage is an altered vascularization 
that may lead to infection and wound healing problems, dysesthesia in the retro-
auricular area and alopecia. For solving these problems, a less invasive technique 
by using a linear retro-auricular incision has been proposed and currently is the 
mostly used. The main benefit of this new technique is the good preservation of 
the vascularization in the surgical area that allows to avoid all the problems of 
muscle-cutaneous flap (infection, healing problems, dysesthesia, etc.). Another 
suggested low invasive technique is based on the removal of a very small piece 
of skin in the area in which the titanium implant should be placed. The skin 
removed has the same dimension of a biopsy. This technique also presents the 
advantages of the liner incision, due to the reduced trauma on tissue and vascular 
structures [30].
7.1 BAHA®(https://www.cochlear.com/it/home) and PONTO® (https://www.
oticonmedical.com/it)
See Figures 10 and 11.
7.2 Alpha 2 (www.sophono.com)
The Alpha 2 by Sophono is another bone-anchored prosthesis without percuta-
neous screw and consists of a processor that is coupled to the skin transcutaneously 
with a titanium component implanted subcutaneously, containing two magnets. 
Figure 10. 
(A) BAHI model is placed on the skin exactly in the area where it will be placed. After considering the distance 
from the superior margin of the external auditory canal, a point is deigned on the skin as landmark. A meter is 
used to measure the distance from the external auditory canal where the BAHI that is approximately 50–55 mm 
is placed. This distance is necessary to avoid the prosthesis from touching the pinna. (B) A line parallel to the 
point previously identified is then designed in the skin of the retro-auricular area. (C) After using the BAHI 
model for designing the location of the implant, a blue mytilene solution is injected for delineating on the 
mastoid bone the lodgment of the implant.
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The magnetic attraction allows to hold the processor in place and to transmit 
acoustic energy [31]. The limits of this kind of  device are represented by energy 
loss through the skin layer and possible discomfort and complications due to soft 
tissue pressure [21] (Figures 12 and 13).
7.3 Bonebridge (https://www.medel.com/hearing-solutions/bonebridge)
The Bonebridge by MED-EL is a semi-implantable bone conduction auditory 
system comprising a processor that is coupled transcutaneously to a titanium 
component and silicone implanted subcutaneously. The transducer, lodged in the 
Figure 13. 
(A) BAHI is placed and fixed with titanium screw. (B) Continuous cutaneous suture to guarantee sterility. 
Live surgery traditional method: https://www.youtube.com/watch?v=AagsHvgsmDs. Live surgery simplified 
method: https://www.youtube.com/watch?v=gJM1jt8W_rI.
Figure 11. 
(A) By using a dermographic pen, the incision line is designed on the skin. (B) After surgical incision the 
lodgment for the bone anchorage is performed by using a drill. (C) The anchorage after the skin closure with 
head in vertical position. Final result. Live surgery: https://www.youtube.com/watch?v=Pz2qZxzkV1I.
Figure 12. 
(A) Musculocutaneous flap with exposure of mastoid (B) using a cutting burr creation of lodgment area.
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mastoid bone, transmits mechanical vibrations directly to the inner ear jumping 
middle and outer ear. The conduction system is light (∼10 g), and it has an area of 
∼8.7 mm (height) × 15.8 mm (diameter). Two titanium screws—responsible for 
the vibrations transduced to the system—are located to a distance of around 24 mm 
between them.
Bonebridge is the unique BAHI with active mechanism; the information ana-
lyzed by the audio-processor are sent to the antenna and transmitted through the 
skin to the system. It converts the received signals into mechanical vibrations, 
which are transmitted to the inner ear by bone conduction. The transductor is surgi-
cally positioned at the seno-dural angle. However, due to its slightly bulky internal 
implant, the most optimal location for placing BB implant should be carefully 
selected preoperatively using 3D reconstruction software [32].
As compared to percutaneous BCI, Bonebridge’s transcutaneous technology 
enables the avoidance of several complications including skin reaction, growth of 
skin over the abutment, implant extrusion, and wound infection.
BB presents the same risks of the other BAHIs (skin infection and skin necrosis), 
and currently nobody described severe complications by using this implant. We 
suggest to use a double flap for minimizing the skin trauma and improving the 
outcomes (Figures 14 and 15).
Figure 15. 
(A) After lodged BAHI is fixed to the temporal bone with a screw and (B) way in which the implant appears 
before the closure of the skin. Live surgery: https://www.youtube.com/watch?v=Wlh6YxEnJl8.
Figure 14. 
(A) Measurement of temporal bone thickness before surgery and (B) lodgment for BAHI created posteriorly to 
the pinna.
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8. Our results
We widely use BAHIs both in the case of aural atresia (singular or bilateral form) 
[1, 15, 21] and as treatment of single side deafness [1], and our results are supported 
by other authors’ observations [16–19, 29, 30].
We observed that BAHI not only improved the hearing abilities of children in 
noise condition but also their dictation capacity during the school activity [1, 15, 21].
We compared children wearing BAHI immediately after the implant and then 
3 months later they were implanted, and we noticed that their abilities in speech 
perception increased time by time by reaching the same scores observed in healthy 
children after 3 months [1]. In addition, we analyzed the short and working mem-
ory abilities in children with BAHI, before and after implantation, and we identified 
that both these memory functions improved by restoring the hearing with BAHIs. 
The memory abilities, as the speech perception done, increased time by time by 
overlapping the score obtained by healthy children in the same age range [1]. 
Finally, we observed that children after being implanted with BAHI improved their 
school scores and increased their relationship with friend and environment [21].
Reported complications are slight skin problems as localized irritation and 
hypertropic scare around the titanium implant. The skin inflammation may be 
explained as an immune answer to an external body (the screw). In the literature 
the rates go from 5 to 7.5% for skin regrowth and from 1.3–10% for extrusion of the 
abutment [15].
9. Conclusions
We think that BAHIs are a very good solution for restoring hearing abilities. 
Although we have a wide experience on children, due to the excellent results 
obtained on these patients, in terms of speech discrimination but much more for the 
impressive benefit obtained in memory function, we suggest BAHIs as treatment of 
hearing loss in adults’ population too.
As we have shown in our chapter, BAHIs are simple to implant, with very low 
side effects, and their surgery is poor and time-consuming. We speculate that due 
to the new theories on BAHIs’ stimulation of the inner ear [33–37], these implants 
could be a valid alternative to the traditional hearing aids in slight-mild form of 
asymmetric hearing loss; we suggest BAHIs not only in the case of conductive hear-
ing loss (CHL) but also in the sensorineural form (SNHL).
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